Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11841612rdf:typepubmed:Citationlld:pubmed
pubmed-article:11841612lifeskim:mentionsumls-concept:C0017296lld:lifeskim
pubmed-article:11841612lifeskim:mentionsumls-concept:C0008109lld:lifeskim
pubmed-article:11841612lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:11841612lifeskim:mentionsumls-concept:C0035668lld:lifeskim
pubmed-article:11841612pubmed:issue1 Suppllld:pubmed
pubmed-article:11841612pubmed:dateCreated2002-3-7lld:pubmed
pubmed-article:11841612pubmed:abstractTextChimeric RNA/DNA oligonucleotides, emerging as a potential strategy for gene therapy, have been shown to induce site-specific correction of point mutations in several genetic disease models.lld:pubmed
pubmed-article:11841612pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11841612pubmed:languageenglld:pubmed
pubmed-article:11841612pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11841612pubmed:citationSubsetIMlld:pubmed
pubmed-article:11841612pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11841612pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11841612pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11841612pubmed:statusMEDLINElld:pubmed
pubmed-article:11841612pubmed:monthJanlld:pubmed
pubmed-article:11841612pubmed:issn1523-1755lld:pubmed
pubmed-article:11841612pubmed:authorpubmed-author:LaiLi-WenLWlld:pubmed
pubmed-article:11841612pubmed:authorpubmed-author:LienYeong-Hau...lld:pubmed
pubmed-article:11841612pubmed:issnTypeElectroniclld:pubmed
pubmed-article:11841612pubmed:volume61lld:pubmed
pubmed-article:11841612pubmed:ownerNLMlld:pubmed
pubmed-article:11841612pubmed:authorsCompleteYlld:pubmed
pubmed-article:11841612pubmed:paginationS47-51lld:pubmed
pubmed-article:11841612pubmed:meshHeadingpubmed-meshheading:11841612...lld:pubmed
pubmed-article:11841612pubmed:meshHeadingpubmed-meshheading:11841612...lld:pubmed
pubmed-article:11841612pubmed:meshHeadingpubmed-meshheading:11841612...lld:pubmed
pubmed-article:11841612pubmed:meshHeadingpubmed-meshheading:11841612...lld:pubmed
pubmed-article:11841612pubmed:meshHeadingpubmed-meshheading:11841612...lld:pubmed
pubmed-article:11841612pubmed:meshHeadingpubmed-meshheading:11841612...lld:pubmed
pubmed-article:11841612pubmed:meshHeadingpubmed-meshheading:11841612...lld:pubmed
pubmed-article:11841612pubmed:meshHeadingpubmed-meshheading:11841612...lld:pubmed
pubmed-article:11841612pubmed:meshHeadingpubmed-meshheading:11841612...lld:pubmed
pubmed-article:11841612pubmed:year2002lld:pubmed
pubmed-article:11841612pubmed:articleTitleChimeric RNA/DNA oligonucleotide-based gene therapy.lld:pubmed
pubmed-article:11841612pubmed:affiliationDepartment of Medicine, Sections of Endocrinology and Nephrology, University of Arizona Health Sciences Center, Tucson, Arizona 85724, USA.lld:pubmed
pubmed-article:11841612pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11841612pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:11841612pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed